FDA approves first COVID-19 drug: antiviral remdesivir

CP24 Toronto's Breaking News - 23 Oct 2020
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.

Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ...

Nature.com - 23 Apr 2024
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ... ...

COVID-19 Treatments: What We Know So Far > News

Yale Medicine - 26 May 2023
COVID-19 Treatments: What We Know So Far > News ...

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen

University of Minnesota Twin Cities - 17 Apr 2024
Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen ...

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ...

Nature.com - 05 Mar 2024
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ... ...

Formulation and in vitro characterization of nanoemulsions containing remdesivir or licorice extract: A potential ...

ScienceDirect.com - 09 Dec 2023
Formulation and in vitro characterization of nanoemulsions containing remdesivir or licorice extract: A potential ... ...

COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting

Cureus - 23 Dec 2023
COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting ...

Two cases show COVID virus mutating around standard treatment remdesivir

Medical Xpress - 23 Jan 2024
Two cases show COVID virus mutating around standard treatment remdesivir ...

Remdesivir for Hospitalized Patients with COVID-19

Ontario COVID-19 Science Advisory Table - 06 May 2021
Remdesivir for Hospitalized Patients with COVID-19 ...

Safety of Remdesivir in Patients With Reduced Renal Function

DocWire News - 05 Feb 2024
Safety of Remdesivir in Patients With Reduced Renal Function ...

New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19

Business Wire - 05 Mar 2024
New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19 ...

Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an ...

CMAJ Open - 01 Sep 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an ... ...

The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug

Science - 28 Oct 2020
The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug ...

DISPATCH From CROI 2024

Infectious Disease Special Edition - 14 Apr 2024
DISPATCH From CROI 2024 ...

Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ...

ScienceDirect.com - 04 Nov 2023
Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ... ...

Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen

University of Minnesota Twin Cities - 22 Sep 2023
Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen ...

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ...

Nature.com - 12 Feb 2024
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ... ...

Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization

ScienceDirect.com - 15 Oct 2023
Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization ...

Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems

University of Minnesota Twin Cities - 10 Aug 2023
Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems ...

Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports

Nature.com - 15 Sep 2023
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports ...

Remdesivir